Login
Navigate Fool.com
Will CVM beat
the market?

CEL-SCI Corp (NYSEMKT: CVM)

Community Rating: 2 Stars: Unattractive

1.17 0.02 (1.74%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.20
Previous Close $1.15
Daily Range $1.16 - $1.20
52-Week Range $0.53 - $2.75
Market Cap $77.1M
P/E Ratio -1.62
Dividend (Yield) $0.00 (0.0%)
Volume 197,530
Average Daily Volume 436,384
Current FY EPS $0.00

How do you think CVM
will perform against the market?

Top CVM Bull/Bear Pitches

 

ejad1 (0)
Submitted January 16, 2014

CVM is expecting to conclude its phase III of Multikrine end 2014 or early 2015

1 Replies Reply Report this Post
 

zzlangerhans (< 20)
Submitted January 22, 2014

It's good to have stocks like Cel-Sci around, because they serve as a barometer of insanity. When there's a sustained rise in Cel-Sci's share price, it's a good indication that nothing that's happenin … More

3 Replies Reply Report this Post

News & Commentary Rss Feed

Sector

Healthcare

Industry

Drugs

CEL-SCI Corp (CVM) Description

The Company engages in the research and development of drugs and vaccines. Its most advanced product, Multikine, manufactured using the Company's proprietary cell culture technologies, is being developed for the treatment of cancer. Website: http://www.cel-sci.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks